Still a hidden Gem with those numbers reported...
Outstanding Shares
37,667,581
04/11/2022
Forward events too..
"We are currently meeting multiple government and private needs for testing related to the COVID-19 pandemic. This includes our participation in the federal government's Test-to-Treat program. In addition, with the launch of our international clinical trial program for medical device manufacturers needing to file either an Emergency Use Authorization (EUA) or a 510K clearance with the FDA, we've reached a new plateau in our range of offered services that we believe will carry us well into the future.
"We also are preparing the launch of a new line of supplements to boost immune systems specifically targeting colds, flu, inflammation and cell mutations. While this is a highly competitive business, we believe our trusted position in the market as a company with an A+ Better Business Bureau rating gives us valuable competitive advantages," Govatski said.